June 1, 2020
The National Center for Global Health and Medicine (NCGM) said on May 29 that it has enrolled 26 patients for its clinical trial evaluating Teijin’s Alvesco (ciclesonide), an inhaled corticosteroid for asthma, for the treatment of patients infected with the...read more